LT4545101T - Stabilūs, koncentruoti radionuklidų kompleksų tirpalai - Google Patents

Stabilūs, koncentruoti radionuklidų kompleksų tirpalai

Info

Publication number: LT4545101T
Authority: LT; Lithuania
Prior art keywords: stable; complex solutions; radionuclide complex; concentrated; concentrated radionuclide
Prior art date: 2018-07-25

Application number

LTEP25162396.3T

Other languages

English (en)

Inventor

Daniela Chicco

Donato BARBATO

Francesco DE PALO

Lorenza Fugazza

Maurizio Mariani

Giovanni TESORIERE

Clementina BRAMBATI

Original Assignee

Advanced Accelerator Applications S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-07-25

Filing date

2018-09-25

Publication date

2026-03-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=63794577&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT4545101(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-07-25 Priority claimed from PCT/IB2018/055575 external-priority patent/WO2020021310A1/en

2018-07-25 Priority claimed from US16/045,484 external-priority patent/US20200030465A1/en

2018-09-25 Application filed by Advanced Accelerator Applications S.A. filed Critical Advanced Accelerator Applications S.A.

2026-03-10 Publication of LT4545101T publication Critical patent/LT4545101T/lt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
- A61K51/048—DTPA (diethylenetriamine tetraacetic acid)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/121—Solutions, i.e. homogeneous liquid formulation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dispersion Chemistry (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

LTEP25162396.3T 2018-07-25 2018-09-25 Stabilūs, koncentruoti radionuklidų kompleksų tirpalai LT4545101T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/IB2018/055575 WO2020021310A1 (en)	2018-07-25	2018-07-25	Stable, concentrated radionuclide complex solutions
US16/045,484 US20200030465A1 (en)	2018-07-25	2018-07-25	Stable, concentrated radionuclide complex solutions

Publications (1)

Publication Number	Publication Date
LT4545101T true LT4545101T (lt)	2026-03-10

Family

ID=63794577

Family Applications (6)

Application Number	Title	Priority Date	Filing Date
LTEPPCT/IB2018/057415T LT3826686T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
LTEP25162396.3T LT4545101T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
LTEP25162394.8T LT4545100T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
LTEP25162391.4T LT4541380T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
LTEP25162390.6T LT4541379T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
LTEP25162403.7T LT4541381T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
LTEPPCT/IB2018/057415T LT3826686T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai

Family Applications After (4)

Application Number	Title	Priority Date	Filing Date
LTEP25162394.8T LT4545100T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
LTEP25162391.4T LT4541380T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
LTEP25162390.6T LT4541379T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
LTEP25162403.7T LT4541381T (lt)	2018-07-25	2018-09-25	Stabilūs, koncentruoti radionuklidų kompleksų tirpalai

Country Status (23)

Country	Link
EP (7)	EP4640241A3 (lt)
JP (3)	JP7402218B2 (lt)
KR (4)	KR102865113B1 (lt)
CN (5)	CN120860272A (lt)
AU (6)	AU2018433575B2 (lt)
BR (1)	BR112021001148A2 (lt)
CA (1)	CA3153630A1 (lt)
CO (1)	CO2021000506A2 (lt)
DE (3)	DE202018007007U1 (lt)
DK (6)	DK4541379T3 (lt)
ES (2)	ES3038413T3 (lt)
FI (6)	FI4541380T3 (lt)
HR (6)	HRP20260100T1 (lt)
HU (1)	HUE072720T2 (lt)
IL (4)	IL319541B2 (lt)
LT (6)	LT3826686T (lt)
MX (2)	MX2021000805A (lt)
PL (5)	PL4545100T3 (lt)
PT (6)	PT4541380T (lt)
RS (5)	RS67729B1 (lt)
SG (1)	SG11202100645XA (lt)
SI (3)	SI4545100T1 (lt)
WO (1)	WO2020021322A1 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11541134B1 (en)	2021-08-02	2023-01-03	Rayzebio, Inc.	Stabilized compositions of radionuclides and uses thereof
WO2023100852A1 (ja) *	2021-11-30	2023-06-08	日本メジフィジックス株式会社	安定化放射性医薬組成物
CN118159303A (zh) *	2022-02-04	2024-06-07	先进加速器应用公司	用于大规模合成放射性核素络合物的方法
CN114404618A (zh) *	2022-03-28	2022-04-29	北京先通国际医药科技股份有限公司	放射性药物水溶液及其用途
CN114404619A (zh) *	2022-03-28	2022-04-29	北京先通国际医药科技股份有限公司	放射性药物水溶液及其制备方法和用途
CN116920129A (zh) *	2022-04-02	2023-10-24	北京先通国际医药科技股份有限公司	放射性药物水溶液及其制备方法和用途
US20260102526A1 (en) *	2024-06-27	2026-04-16	Curium Us Llc	177lutetium-dota-tate formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2779780A (en)	1955-03-01	1957-01-29	Du Pont	1, 4-diamino-2, 3-dicyano-1, 4-bis (substituted mercapto) butadienes and their preparation
US4261989A (en)	1979-02-19	1981-04-14	Kaken Chemical Co. Ltd.	Geldanamycin derivatives and antitumor drug
EP0647450A1 (en)	1993-09-09	1995-04-12	BEHRINGWERKE Aktiengesellschaft	Improved prodrugs for enzyme mediated activation
US6066309A (en) *	1996-02-02	2000-05-23	Rhomed Incorporated	Post-labeling stabilization of radiolabeled proteins and peptides
AU776788C (en)	1998-12-16	2005-10-27	Warner-Lambert Company	Treatment of arthritis with MEK inhibitors
DZ3401A1 (fr)	2000-07-19	2002-01-24	Warner Lambert Co	Esters oxygenes d'acides 4-iodophenylamino benzhydroxamiques
US6995162B2 (en)	2001-01-12	2006-02-07	Amgen Inc.	Substituted alkylamine derivatives and methods of use
JP4547911B2 (ja)	2002-02-01	2010-09-22	アリアド・ファーマシューティカルズ・インコーポレイテッド	リン含有化合物およびその用途
AU2003224672B2 (en)	2002-03-08	2010-02-04	Eisai R&D Management Co., Ltd.	Macrocyclic compounds useful as pharmaceuticals
SG2013013339A (en)	2002-03-13	2014-12-30	Array Biopharma Inc	N3 alkylated benzimidazole derivatives as mek inhibitors
TWI275390B (en)	2002-04-30	2007-03-11	Wyeth Corp	Process for the preparation of 7-substituted-3- quinolinecarbonitriles
CA2526556C (en)	2003-07-24	2012-09-25	Bracco Imaging S.P.A.	Stable radiopharmaceutical compositions and methods for their preparation
MX2008002114A (es)	2005-07-21	2008-04-17	Ardea Biosciences Inc	Inhibidores de n-(arilamino)-sulfonamida de mek.
WO2008009444A1 (en)	2006-07-19	2008-01-24	Van Dulmen, Adrianus, A.	Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide
AU2017354941B2 (en) *	2016-11-04	2021-02-11	Clarity Pharmaceuticals Ltd	Formulations for radiotherapy and diagnostic imaging
US10596276B2 (en)	2018-07-25	2020-03-24	Advanced Accelerator Applications (Italy) S.R.L.	Stable, concentrated radionuclide complex solutions

2018
- 2018-09-25 DK DK25162390.6T patent/DK4541379T3/da active
- 2018-09-25 HR HRP20260100TT patent/HRP20260100T1/hr unknown
- 2018-09-25 RS RS20260150A patent/RS67729B1/sr unknown
- 2018-09-25 LT LTEPPCT/IB2018/057415T patent/LT3826686T/lt unknown
- 2018-09-25 SG SG11202100645XA patent/SG11202100645XA/en unknown
- 2018-09-25 RS RS20260085A patent/RS67667B1/sr unknown
- 2018-09-25 LT LTEP25162396.3T patent/LT4545101T/lt unknown
- 2018-09-25 FI FIEP25162391.4T patent/FI4541380T3/fi active
- 2018-09-25 LT LTEP25162394.8T patent/LT4545100T/lt unknown
- 2018-09-25 LT LTEP25162391.4T patent/LT4541380T/lt unknown
- 2018-09-25 DE DE202018007007.6U patent/DE202018007007U1/de active Active
- 2018-09-25 EP EP25200826.3A patent/EP4640241A3/en active Pending
- 2018-09-25 DK DK25162394.8T patent/DK4545100T3/da active
- 2018-09-25 RS RS20260183A patent/RS67755B1/sr unknown
- 2018-09-25 HR HRP20260222TT patent/HRP20260222T1/hr unknown
- 2018-09-25 CN CN202511294891.0A patent/CN120860272A/zh active Pending
- 2018-09-25 IL IL319541A patent/IL319541B2/en unknown
- 2018-09-25 HR HRP20260237TT patent/HRP20260237T1/hr unknown
- 2018-09-25 JP JP2021504167A patent/JP7402218B2/ja active Active
- 2018-09-25 CN CN202511294619.2A patent/CN121081692A/zh active Pending
- 2018-09-25 KR KR1020247006883A patent/KR102865113B1/ko active Active
- 2018-09-25 EP EP18783136.7A patent/EP3826686B1/en active Active
- 2018-09-25 FI FIEP25162403.7T patent/FI4541381T3/fi active
- 2018-09-25 EP EP25162396.3A patent/EP4545101B1/en active Active
- 2018-09-25 DE DE202018007006.8U patent/DE202018007006U1/de active Active
- 2018-09-25 PT PT251623914T patent/PT4541380T/pt unknown
- 2018-09-25 PL PL25162394.8T patent/PL4545100T3/pl unknown
- 2018-09-25 PL PL18783136.7T patent/PL3826686T3/pl unknown
- 2018-09-25 BR BR112021001148-0A patent/BR112021001148A2/pt unknown
- 2018-09-25 EP EP25162390.6A patent/EP4541379B1/en active Active
- 2018-09-25 KR KR1020217005212A patent/KR102643582B1/ko active Active
- 2018-09-25 EP EP25162391.4A patent/EP4541380B1/en active Active
- 2018-09-25 PT PT251624037T patent/PT4541381T/pt unknown
- 2018-09-25 WO PCT/IB2018/057415 patent/WO2020021322A1/en not_active Ceased
- 2018-09-25 DK DK25162396.3T patent/DK4545101T3/da active
- 2018-09-25 FI FIEP25162390.6T patent/FI4541379T3/fi active
- 2018-09-25 DK DK25162403.7T patent/DK4541381T3/da active
- 2018-09-25 HR HRP20260179TT patent/HRP20260179T1/hr unknown
- 2018-09-25 PT PT251623963T patent/PT4545101T/pt unknown
- 2018-09-25 PL PL25162396.3T patent/PL4545101T3/pl unknown
- 2018-09-25 DE DE202018006567.6U patent/DE202018006567U1/de active Active
- 2018-09-25 IL IL319542A patent/IL319542B1/en unknown
- 2018-09-25 PL PL25162390.6T patent/PL4541379T3/pl unknown
- 2018-09-25 PT PT187831367T patent/PT3826686T/pt unknown
- 2018-09-25 HR HRP20250912TT patent/HRP20250912T1/hr unknown
- 2018-09-25 EP EP25162403.7A patent/EP4541381B1/en active Active
- 2018-09-25 LT LTEP25162390.6T patent/LT4541379T/lt unknown
- 2018-09-25 RS RS20260182A patent/RS67754B1/sr unknown
- 2018-09-25 ES ES18783136T patent/ES3038413T3/es active Active
- 2018-09-25 ES ES25162390T patent/ES3063402T3/es active Active
- 2018-09-25 CN CN201880095724.5A patent/CN112584875A/zh active Pending
- 2018-09-25 EP EP25162394.8A patent/EP4545100B1/en active Active
- 2018-09-25 MX MX2021000805A patent/MX2021000805A/es unknown
- 2018-09-25 RS RS20250737A patent/RS67034B1/sr unknown
- 2018-09-25 SI SI201831303T patent/SI4545100T1/sl unknown
- 2018-09-25 DK DK25162391.4T patent/DK4541380T3/da active
- 2018-09-25 HR HRP20260338TT patent/HRP20260338T1/hr unknown
- 2018-09-25 SI SI201831251T patent/SI3826686T1/sl unknown
- 2018-09-25 PT PT251623948T patent/PT4545100T/pt unknown
- 2018-09-25 CN CN202511294533.XA patent/CN120860270A/zh active Pending
- 2018-09-25 IL IL313560A patent/IL313560B2/en unknown
- 2018-09-25 AU AU2018433575A patent/AU2018433575B2/en active Active
- 2018-09-25 LT LTEP25162403.7T patent/LT4541381T/lt unknown
- 2018-09-25 FI FIEP18783136.7T patent/FI3826686T3/fi active
- 2018-09-25 DK DK18783136.7T patent/DK3826686T3/da active
- 2018-09-25 KR KR1020267005571A patent/KR20260030955A/ko active Pending
- 2018-09-25 HU HUE18783136A patent/HUE072720T2/hu unknown
- 2018-09-25 CA CA3153630A patent/CA3153630A1/en active Pending
- 2018-09-25 PT PT251623906T patent/PT4541379T/pt unknown
- 2018-09-25 KR KR1020257001675A patent/KR102932818B1/ko active Active
- 2018-09-25 SI SI201831295T patent/SI4541379T1/sl unknown
- 2018-09-25 FI FIEP25162396.3T patent/FI4545101T3/fi active
- 2018-09-25 FI FIEP25162394.8T patent/FI4545100T3/fi active
- 2018-09-25 CN CN202511294583.8A patent/CN120860271A/zh active Pending
- 2018-09-25 PL PL25162391.4T patent/PL4541380T3/pl unknown
2021
- 2021-01-20 MX MX2025012060A patent/MX2025012060A/es unknown
- 2021-01-20 IL IL280314A patent/IL280314A/en unknown
- 2021-01-20 CO CONC2021/0000506A patent/CO2021000506A2/es unknown
2022
- 2022-05-30 AU AU2022203683A patent/AU2022203683B2/en active Active
2023
- 2023-05-24 JP JP2023085193A patent/JP7796696B2/ja active Active
2024
- 2024-02-23 AU AU2024201217A patent/AU2024201217B2/en active Active
2025
- 2025-03-18 JP JP2025043874A patent/JP2025111424A/ja active Pending
- 2025-03-27 AU AU2025202231A patent/AU2025202231A1/en active Pending
- 2025-06-27 AU AU2025204901A patent/AU2025204901B2/en active Active
- 2025-08-22 AU AU2025220852A patent/AU2025220852B2/en active Active

Also Published As

Publication number	Publication date
ES3038413T3 (en)	2025-10-13
CA3153630A1 (en)	2020-01-30
IL319541A (en)	2025-05-01
DE202018007006U1 (de)	2025-11-13
EP4541380B1 (en)	2025-12-10
EP4541381A3 (en)	2025-07-23
CN120860271A (zh)	2025-10-31
AU2025202231A1 (en)	2025-04-17
RS67034B1 (sr)	2025-08-29
KR20210035855A (ko)	2021-04-01
LT4545100T (lt)	2026-02-25
DK4545100T3 (da)	2026-02-23
DK3826686T3 (da)	2025-08-25
FI4541379T3 (fi)	2026-02-17
JP2025111424A (ja)	2025-07-30
HRP20250912T1 (hr)	2025-09-26
EP3826686A1 (en)	2021-06-02
EP4545100A3 (en)	2025-07-23
AU2025220852B2 (en)	2025-10-23
IL313560B2 (en)	2025-11-01
IL319541B2 (en)	2026-01-01
CN112584875A (zh)	2021-03-30
FI3826686T3 (fi)	2025-08-20
RS67729B1 (sr)	2026-03-31
CN120860272A (zh)	2025-10-31
FI4541381T3 (fi)	2026-04-01
PT4541379T (pt)	2026-01-29
AU2018433575A1 (en)	2021-02-11
IL313560A (en)	2024-08-01
AU2018433575B2 (en)	2022-07-07
MX2025012060A (es)	2025-11-03
PL4545100T3 (pl)	2026-03-30
BR112021001148A2 (pt)	2021-04-20
PL4541379T3 (pl)	2026-03-23
DK4541379T3 (da)	2026-02-02
PT4541381T (pt)	2026-03-17
HRP20260237T1 (hr)	2026-04-10
PT3826686T (pt)	2025-08-04
SI4541379T1 (sl)	2026-03-31
AU2022203683A1 (en)	2022-06-16
MX2021000805A (es)	2021-05-12
EP4541379B1 (en)	2025-11-19
SI4545100T1 (sl)	2026-03-31
EP4541381B1 (en)	2026-02-04
EP4541380A3 (en)	2025-07-23
JP7402218B2 (ja)	2023-12-20
EP4541379A2 (en)	2025-04-23
FI4541380T3 (fi)	2026-03-02
JP2022501313A (ja)	2022-01-06
CN121081692A (zh)	2025-12-09
AU2025204901A1 (en)	2025-07-17
EP4545101A3 (en)	2025-07-23
AU2025220852A1 (en)	2025-09-11
PT4545101T (pt)	2026-02-24
PT4545100T (pt)	2026-02-16
RS67667B1 (sr)	2026-02-27
PL4545101T3 (pl)	2026-03-30
KR102865113B1 (ko)	2025-09-26
HRP20260179T1 (hr)	2026-04-10
EP4640241A3 (en)	2025-12-10
PL3826686T3 (pl)	2025-09-22
HRP20260338T1 (hr)	2026-04-10
EP4541381A2 (en)	2025-04-23
AU2024201217B2 (en)	2025-02-27
PT4541380T (pt)	2026-02-24
IL319541B1 (en)	2025-09-01
FI4545101T3 (fi)	2026-02-24
JP7796696B2 (ja)	2026-01-09
LT4541380T (lt)	2026-03-10
EP4545100A2 (en)	2025-04-30
EP4541380A2 (en)	2025-04-23
CN120860270A (zh)	2025-10-31
CO2021000506A2 (es)	2021-04-19
IL319542B1 (en)	2026-04-01
IL313560B1 (en)	2025-07-01
RS67755B1 (sr)	2026-03-31
LT4541381T (lt)	2026-03-25
SG11202100645XA (en)	2021-02-25
ES3063402T3 (en)	2026-04-16
EP4640241A2 (en)	2025-10-29
SI3826686T1 (sl)	2025-09-30
EP4545101A2 (en)	2025-04-30
AU2022203683B2 (en)	2023-12-21
KR102932818B1 (ko)	2026-03-03
RS67754B1 (sr)	2026-03-31
DK4541380T3 (da)	2026-02-23
DK4545101T3 (da)	2026-03-02
IL280314A (en)	2021-03-25
PL4541380T3 (pl)	2026-03-30
LT4541379T (lt)	2026-02-10
IL319542A (en)	2025-05-01
LT3826686T (lt)	2025-08-25
FI4545100T3 (fi)	2026-03-02
DK4541381T3 (da)	2026-04-07
HRP20260100T1 (hr)	2026-04-10
KR20240033296A (ko)	2024-03-12
HRP20260222T1 (hr)	2026-03-27
EP4545100B1 (en)	2025-12-10
AU2024201217A1 (en)	2024-03-14
DE202018006567U1 (de)	2021-04-01
KR20260030955A (ko)	2026-03-06
EP3826686B1 (en)	2025-05-21
DE202018007007U1 (de)	2025-11-13
KR102643582B1 (ko)	2024-03-05
EP4541379A3 (en)	2025-07-23
KR20250017751A (ko)	2025-02-04
HUE072720T2 (hu)	2025-12-28
EP4545101B1 (en)	2025-12-10
AU2025204901B2 (en)	2025-09-18
JP2023117417A (ja)	2023-08-23
WO2020021322A1 (en)	2020-01-30

Publication	Publication Date	Title
CA185390S (en)	2020-01-20	Stroller
ES3063402T3 (en)	2026-04-16	Stable, concentrated radionuclide complex solutions
GB201907131D0 (en)	2019-07-03	Stroller
GB201913519D0 (en)	2019-11-06	Multi-zone, single trip completion system
ZA201705301B (en)	2025-02-26	Radiopharmaceutical solutions with advantageous properties
PL3231417T3 (pl)	2019-05-31	Odporna na składowanie kompozycja oftalmiczna
Joshi	2014	Jahaj Ka Panchhi
Dickinson	2015	Thebes (1), prehistoric
杨乐	2015	Are you ready... Go
GB201715900D0 (en)	2017-11-15	Palate-transducers & palate-loudspeakers, new drawings
PH32019000209S1 (en)	2019-06-03	Stroller
AU201815032S (en)	2018-09-21	Stroller
Fool et al.	2015	Watch
AU201811518S (en)	2018-04-05	Stroller
GB201810857D0 (en)	2018-08-15	Pushchair
GB201711113D0 (en)	2017-08-23	.
HUP1600486A2 (en)	2018-02-28	Smart mobile cabinet, especially saddle cabinet
GB201703513D0 (en)	2017-04-19	Drivesafe.
GB201602981D0 (en)	2016-04-06	Back-covered can, BCC
AU2017161V (en)	2017-06-09	GR13008 Grevillea .
AU2017160V (en)	2017-06-09	GR13002 Grevillea .
GB201506170D0 (en)	2015-05-27	Discuss, inspire, achieve (discussinspireachieve.com)
GB201513244D0 (en)	2015-09-09	Atmopherically assisted L.E.N.R.
GB201501738D0 (en)	2015-03-18	S.o.s.i.c.h.